Estudo de coorte | Seguimento de longo prazo mostrou que a maioria das crianças com síndrome inflamatória multissistêmica pós-COVID-19 teve bons desfechos, sem sequelas significativas no médio ou no longo prazo.
12 Set, 2021 | 22:14hComentário: Outcome Good at One Year for Majority of PIMS-TS Patients – HealthDay
Comentário no Twitter
A new study reports that a small number of pediatric patients are at risk for poor long-term outcomes of multisystem inflammatory syndrome in children. https://t.co/rUk4YEGRin pic.twitter.com/CgBi33Mzd5
— JAMA Pediatrics (@JAMAPediatrics) September 2, 2021